FDA Issues Emergency Use Authorization for 2-Minute Coronavirus Test
By Reuters
March 31, 2020
•1 min read
Source: Unsplash, Fusion Medical Animation
By Manas Mishra
(Reuters) – The U.S. Food and Drug Administration has authorized the emergency use of Bodysphere Inc’s test that can detect the coronavirus in nearly two minutes, the privately held company said on Tuesday.
The FDA has been rushing to approve tests on an emergency basis and last week approved Abbott Laboratories’ test that can deliver results within minutes.
Bodysphere said it was working with the federal and state governments to deliver the test to the frontlines.
The test is administered like a glucose test but is designed for use strictly by medical professionals.
Editing by Shailesh Kuber.
_____
Source: Reuters
Trending Now
2
Private Investments
5
Read Next
Private Investments
The Impact: Focusing private wealth on impact investing
Jeff Gitterman
Apr 17, 2024
Environment
Corporate climate plans are improving, but still ‘critically insufficient’
Grist
Apr 17, 2024
Education
Personalized cancer therapy can lead to faster treatments, better outcomes
The Conversation
Apr 16, 2024
Economic
GreenMoney: Investing in the future of water and sanitation
Green Money
Apr 16, 2024
Investing Strategies
Empowering every investor: bridging values and finance for a sustainable future
Adam Koprucki
Apr 15, 2024
Environment
Taxing polluters is the key to climate justice
Project Syndicate
Apr 15, 2024
The Latest
Private Investments
The Impact: Focusing private wealth on impact investing
Apr 17, 2024
Environment
Corporate climate plans are improving, but still ‘critically insufficient’
Apr 17, 2024
Education
Personalized cancer therapy can lead to faster treatments, better outcomes
Apr 16, 2024
Economic
GreenMoney: Investing in the future of water and sanitation
Apr 16, 2024